Sonnerie VC
Overview
Sonnerie VC is an early-stage, operator-led venture capital firm investing in healthcare, life sciences, and technology companies in regulated markets. The firm focuses on backing disciplined founders building platforms, AI, diagnostics, and infrastructure, emphasizing clarity over noise. Their investment strategy targets seed to early-stage companies, including Series A and B rounds, with a geographical focus on the United States. Sonnerie VC's portfolio includes companies like BMI OrganBank, a life sciences firm specializing in organ preservation and transplant medicine. The firm's investment philosophy centers on practical execution, disciplined capital allocation, and long-term value creation, aiming to support transformative ventures in the healthcare and technology sectors.
Investment Focus
- Disciplined founders building platforms, AI, diagnostics, and infrastructure in regulated markets
Portfolio Companies
Reach Sonnerie VC directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Sonnerie VC
What sectors does Sonnerie VC invest in?
Sonnerie VC invests in Technology, Healthcare and Life Sciences, and is based in United States. Sonnerie VC is listed as a venture capital in the ConnectSafely investor database.
What stage does Sonnerie VC invest at?
Sonnerie VC backs companies at Seed, Early Stage, Series A and Series B.
Which regions does Sonnerie VC invest in?
Sonnerie VC invests across United States.
What companies has Sonnerie VC invested in?
Sonnerie VC's portfolio includes BMI OrganBank.
Last updated · Source: ConnectSafely investor database